GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
Shohei Ohtani Japan Venezuela World Baseball Classic quarterfinal upset sees defending champions eliminated 8-5 despite Ohtani's home run as Venezuela advances....
The Florida Federation of College Republicans disbanded its University of Florida chapter and asked the school to remove it as a student organization due to alleged misconduct that includes antisemiti...
Americans describe being stranded in Dubai and Israel as conflict with Iran triggers airspace closures, flight cancellations and evacuation challenges....
